Xsensio raises USD 7 M

Xsensio is developing Lab-on-Skin, a platform of wearable biosensors that continuously measure biochemical biomarkers. The company is raising USD 7 million in a Series A led by WI Harper to accelerate its clinical validation.

Announced on
Round
Series A
Amount
USD 7 M
Location
Lausanne, canton of Vaud
Sector
Health & medtech, Deep tech

Investors

Preparing a similar round?

The diagnostic shows you the instruments and investors that fit your stage.

Start the diagnostic